AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

NDA accepted for filing by FDA for extended-regimen oral contraceptive.(Barr Laboratories Inc.'s new drug application for Seasonale oral contracptive accepted )(Brief Article)

Women's Health Weekly

| November 07, 2002 | COPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2002 NOV 7 - (NewsRx.com & NewsRx.net) -- Barr Laboratories, Inc., (BRL) announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's new drug application (NDA) for its Seasonale extended regimen oral contraceptive.

The company is seeking approval to manufacture and market Seasonale extended regimen oral contraceptive for the prevention of pregnancy. This represents the first NDA filing by the company.

"We are pleased to announce that our Seasonale NDA has been accepted by the FDA for review," said Dr. Carole S. Ben-Maimon, president and COO of Barr Research. "While acceptance for filing of an NDA does not assure approval, we believe our clinical data indicates that the Seasonale extended oral contraceptive therapy appears to prevent pregnancy and has a comparable safety profile to more traditional oral contraceptives. If granted final FDA approval, we expect that the Seasonale regimen will provide women with a choice in the area of birth control, especially those women who prefer the convenience of fewer ...

Related articles from newspapers, magazines, journals, and more
Duramed Receives Approval for Enpresse, an AB Rated Triphasic Regimen...
Press release article from: Business Wire July 17, 2001 700+ words
...joins Duramed's growing oral contraceptive product line Duramed Pharmaceuticals...tablets), a triphasic regimen oral contraceptive drug product. Duramed...ethinyl estradiol triphasic regimen oral contraceptive drug products exceeded...
Continuous regimen OCs: Will U.S. see new pill?(oral contraceptive )
Magazine article from: Contraceptive Technology Update January 1, 2006 700+ words
...now be using the extended regimen oral contraceptive (OC) Seasonale (Barr...be the first combination oral contraceptive approved designed to be...with currently available oral contraceptive products. The efficacy...
Decreased maximal aerobic capacity with use of a triphasic oral contraceptive...
Magazine article from: British Journal of Sports Medicine Lebrun, CM Petit, MA McKenzie, DC Taunton, JE Prior, JC August 1, 2003 700+ words
...of a moderate dose, triphasic oral contraceptive on measures of athletic performance...assigned to either a tricyclic oral contraceptive or placebo and retested in identical fashion (oral contraceptive phase). Results: Absolute...
A new combined oral contraceptive pill: Yasmin.(New therapies: a guide to...
Magazine article from: Practice Nurse April 26, 2002 700+ words
...women in the UK used the combined oral contraceptive pill for contraception and numbers...launch of the first new combined oral contraceptive pill (COC) in the UK for ten years...TOLERABILITY Yasmin, like other combined oral contraceptive pills, still has side-effects...
Oral contraceptive use among teenagers in Finland.(ROUND UP: Service Delivery)
Magazine article from: Reproductive Health Matters May 1, 2007 700+ words
...authors to investigate changes in oral contraceptive use among 14-18 year old girls...girls over a period of 22 years. Oral contraceptive use rose between 1981 and 1991 from...regional and family factors in oral contraceptive use. In both decades early age at...
BIOSANTE PHARMA ANNOUNCES ORAL CONTRACEPTIVE PHASE II STUDY.(Clinical report)
News wire article from: AsiaPulse News June 20, 2007 700+ words
...BioSante Pharmaceuticals Announces Oral Contraceptive Phase II Study Initiation LINCOLNSHIRE...human clinical trial of a new oral contraceptive. BioSante will co-fund the development of the oral contraceptive up to $1.0 million. Pantarhei...
An oral contraceptive perception scale for female adolescents.
Magazine article from: Western Journal of Nursing Research Hanna, Kathleen M. August 1, 1997 700+ words
...to adolescents' lack of adherence to oral contraceptive regimes. The oral contraceptive pill is the most frequently used method...adolescents have relatively low levels of oral contraceptive adherence, between 10% and 70...
BioSante Pharmaceuticals Announces Oral Contraceptive Phase II Study...
Press release article from: Business Wire June 19, 2007 700+ words
...human clinical trial of a new oral contraceptive. BioSante will co-fund the development of the oral contraceptive up to $1.0 million. Pantarhei...the effect of a new patented oral contraceptive on sexual arousability and the...
Barr Receives Approvable Letter for Duramed's SEASONIQUE(TM) Extended-Cycle...
Press release article from: PR Newswire August 18, 2005 700+ words
...tablets 0.01 mg) extended-cycle oral contraceptive. To achieve final approval, the...that our SEASONIQUE extended-cycle oral contraceptive product is approvable for the prevention...committed to the extended-cycle oral contraceptive category it created with the launch...
ORTHO EXPANDS ITS ORAL CONTRACEPTIVE LINE: INTRODUCES ORTHO-CEPT AND BRINGS...
Press release article from: PR Newswire December 15, 1992 700+ words
...desogestrel/ethinyl estradiol). The new oral contraceptive received market clearance from the...Administration yesterday. The new oral contraceptive, which contains the progestin desogestrel...become the most widely prescribed oral contraceptive since its European introduction in...
For more facts and information, see all results

Source: HighBeam Research, NDA accepted for filing by FDA for extended-regimen oral...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA